Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: GENSCRIPT USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-24 to 2024-09-23
Current total value of award: $3078000
Description: DETECTION OF MUTATION-REACTIVE T-CELLS IN PATIENTS WITH METASTATIC CANCERS